Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20264 analyst targets · 90 days
- Share price
- $7.62
- Average 1Y price target
- $19.33+153.67%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF1
- Return on equity1
- Return on assets1
- Debt / equity1
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 1 | $22.00 |
| Last quarter | 5 | $22.60 |
| Last year | 20 | $24.45 |
| All time | 30 | $26.97 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 25, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 25, 2026 | Baird | maintain | Outperform | Outperform |
| Aug 10, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 7, 2026 | Barclays | downgrade | Overweight | Equal Weight |
| Jun 24, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jun 22, 2026 | Leerink Partners | maintain | Outperform | Outperform |
| Jun 22, 2026 | Baird | maintain | Outperform | Outperform |
| Jun 5, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 15, 2026 | B of A Securities | maintain | Buy | Buy |
| May 15, 2026 | Barclays | maintain | Overweight | Overweight |
| Mar 9, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 6, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Feb 10, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Feb 10, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Feb 10, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Feb 10, 2026 | Chardan Capital | maintain | Buy | Buy |
| Jan 29, 2026 | Chardan Capital | maintain | Buy | Buy |
| Dec 19, 2025 | Stifel | maintain | Buy | Buy |
| Dec 15, 2025 | Leerink Partners | maintain | Outperform | Outperform |
| Nov 20, 2025 | Chardan Capital | maintain | Buy | Buy |
| Nov 7, 2025 | RBC Capital | maintain | Outperform | Outperform |
| Oct 7, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 8, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 8, 2025 | Chardan Capital | maintain | Buy | Buy |
| Aug 19, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 8, 2025 | RBC Capital | maintain | Outperform | Outperform |
| Aug 8, 2025 | Chardan Capital | maintain | Buy | Buy |
| Aug 8, 2025 | Barclays | maintain | Overweight | Overweight |
| Jun 9, 2025 | Chardan Capital | maintain | Buy | Buy |
| Apr 17, 2025 | Goldman Sachs | maintain | Neutral | Neutral |
| Mar 21, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 20, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 20, 2025 | Chardan Capital | maintain | Buy | Buy |
| Mar 17, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 14, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Mar 14, 2025 | Chardan Capital | maintain | Buy | Buy |
| Feb 11, 2025 | Goldman Sachs | downgrade | Buy | Neutral |
| Jan 21, 2025 | RBC Capital | maintain | Outperform | Outperform |
| Jan 15, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Dec 11, 2024 | RBC Capital | maintain | Outperform | Outperform |